By Giovanna Verginelli Mezher

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil … Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good … New subject codes for filing applications for GMP certification for biological products industries